Portfolio company
aprinoia
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biopharmaceutical company develops diagnostic tools and targeted therapeutics for neurodegenerative diseases to serve healthcare providers and patients.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Cajal Neuroscience
This biotechnology company develops drug discovery platforms and therapeutics for neurodegenerative diseases to assist healthcare providers and patients.
Cerevance
This pharmaceutical company develops therapies for neurodegenerative diseases and central nervous system disorders for patients and healthcare providers.
Muna Therapeutics
This biopharmaceutical company develops small-molecule therapeutics to treat neurodegenerative diseases, such as Alzheimer's and Parkinson's, for patients and healthcare providers.
Alzeca Biosciences
This company develops MRI contrast agents to enable early diagnosis of Alzheimer's disease and other neurodegenerative disorders for healthcare providers and clinical researchers.
Neumora Therapeutics
This biopharmaceutical company develops medicines for patients with neuropsychiatric disorders and neurodegenerative diseases.
Athira Pharma
This biopharmaceutical company develops small molecule therapies for patients with neurodegenerative conditions and certain cancers.
Alzinova
This biopharmaceutical company develops immunotherapies and vaccines targeting toxic amyloid-beta oligomers to treat and prevent Alzheimer's disease for patients worldwide.
Therapeutics Neurodegenerative diseases
This company develops diagnostic tools and therapeutics for patients with neurodegenerative diseases including Alzheimer's and progressive supranuclear palsy.
